Sangamo Therapeutics, Inc
SGMO
Revenue
7.55M
▼-41.86M▼-84.72%
3 Months ChangeAssets
101.64M
▼-9.63M▼-8.65%
3 Months ChangeLiabilities
78.87M
▲6.74M▲9.34%
3 Months ChangeFree Cash Flow
-48.66M
▲27.84M▲36.39%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-04
Form 8-K
ID: 0001628280-24-042308
2024-08-06
Form 10-Q
ID: 0001628280-24-035165
2024-08-06
Form 8-K
ID: 0001628280-24-035160
2024-07-24
Form 8-K
ID: 0001628280-24-032815
2024-06-05
Form 8-K
ID: 0001628280-24-026903
2024-05-09
Form 10-Q
ID: 0001628280-24-022194
2024-05-09
Form 8-K
ID: 0001628280-24-022186
2024-04-30
Form 8-K
ID: 0001628280-24-019337
2024-03-25
Form 8-K
ID: 0001193125-24-076613
2024-03-13
Form 8-K
ID: 0001628280-24-010790